Annual revenue:
$661.82M+$54.30M(+8.94%)Summary
- As of today (May 29, 2025), SUPN annual revenue is $661.82 million, with the most recent change of +$54.30 million (+8.94%) on December 31, 2024.
- During the last 3 years, SUPN annual revenue has risen by +$82.04 million (+14.15%).
- SUPN annual revenue is now -0.81% below its all-time high of $667.24 million, reached on December 31, 2022.
Performance
SUPN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$149.82M-$24.34M(-13.97%)Summary
- As of today (May 29, 2025), SUPN quarterly revenue is $149.82 million, with the most recent change of -$24.34 million (-13.97%) on March 31, 2025.
- Over the past year, SUPN quarterly revenue has increased by +$6.18 million (+4.30%).
- SUPN quarterly revenue is now -15.52% below its all-time high of $177.35 million, reached on September 30, 2022.
Performance
SUPN Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$668.00M+$6.18M(+0.93%)Summary
- As of today (May 29, 2025), SUPN TTM revenue is $668.00 million, with the most recent change of +$6.18 million (+0.93%) on March 31, 2025.
- Over the past year, SUPN TTM revenue has increased by +$70.60 million (+11.82%).
- SUPN TTM revenue is now -0.07% below its all-time high of $668.50 million, reached on March 31, 2023.
Performance
SUPN TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
SUPN Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.9% | +4.3% | +11.8% |
| 3 y3 years | +14.2% | -1.8% | +11.1% |
| 5 y5 years | +68.5% | +57.8% | +66.1% |
SUPN Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.8% | +14.2% | -15.5% | +10.5% | -0.1% | +11.8% |
| 5 y | 5-year | -0.8% | +68.5% | -15.5% | +57.8% | -0.1% | +66.1% |
| alltime | all time | -0.8% | >+9999.0% | -15.5% | +1836.9% | -0.1% | +7844.0% |
SUPN Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $149.82M(-14.0%) | $668.00M(+0.9%) |
| Dec 2024 | $661.82M(+8.9%) | $174.16M(-0.9%) | $661.82M(+1.5%) |
| Sep 2024 | - | $175.69M(+4.4%) | $651.97M(+3.5%) |
| Jun 2024 | - | $168.32M(+17.2%) | $630.16M(+5.5%) |
| Mar 2024 | - | $143.64M(-12.6%) | $597.40M(-1.7%) |
| Dec 2023 | $607.52M(-8.9%) | $164.31M(+6.8%) | $607.52M(-0.5%) |
| Sep 2023 | - | $153.88M(+13.5%) | $610.53M(-3.7%) |
| Jun 2023 | - | $135.56M(-11.8%) | $634.01M(-5.2%) |
| Mar 2023 | - | $153.76M(-8.1%) | $668.50M(+0.2%) |
| Dec 2022 | $667.24M(+15.1%) | $167.33M(-5.7%) | $667.24M(+1.3%) |
| Sep 2022 | - | $177.35M(+4.3%) | $658.96M(+4.6%) |
| Jun 2022 | - | $170.05M(+11.5%) | $630.07M(+4.8%) |
| Mar 2022 | - | $152.51M(-4.1%) | $601.35M(+3.7%) |
| Dec 2021 | $579.77M(+11.4%) | $159.05M(+7.1%) | $579.77M(+2.7%) |
| Sep 2021 | - | $148.46M(+5.0%) | $564.28M(-1.2%) |
| Jun 2021 | - | $141.33M(+7.9%) | $570.95M(+2.6%) |
| Mar 2021 | - | $130.93M(-8.8%) | $556.35M(+6.9%) |
| Dec 2020 | $520.40M(+32.5%) | $143.56M(-7.5%) | $520.40M(+9.0%) |
| Sep 2020 | - | $155.13M(+22.4%) | $477.29M(+12.5%) |
| Jun 2020 | - | $126.73M(+33.4%) | $424.29M(+5.5%) |
| Mar 2020 | - | $94.98M(-5.4%) | $402.26M(+2.4%) |
| Dec 2019 | $392.75M(-3.9%) | $100.45M(-1.7%) | $392.75M(-3.8%) |
| Sep 2019 | - | $102.14M(-2.4%) | $408.24M(-0.2%) |
| Jun 2019 | - | $104.69M(+22.5%) | $409.10M(+1.3%) |
| Mar 2019 | - | $85.47M(-26.3%) | $403.94M(-1.2%) |
| Dec 2018 | $408.90M(+35.3%) | $115.93M(+12.6%) | $408.90M(+7.2%) |
| Sep 2018 | - | $103.00M(+3.5%) | $381.40M(+6.3%) |
| Jun 2018 | - | $99.54M(+10.1%) | $358.80M(+7.1%) |
| Mar 2018 | - | $90.43M(+2.3%) | $335.09M(+10.9%) |
| Dec 2017 | $302.24M | $88.44M(+10.0%) | $302.24M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $80.40M(+6.0%) | $276.18M(+9.3%) |
| Jun 2017 | - | $75.83M(+31.7%) | $252.59M(+10.6%) |
| Mar 2017 | - | $57.58M(-7.7%) | $228.39M(+6.2%) |
| Dec 2016 | $215.00M(+45.8%) | $62.37M(+9.8%) | $215.00M(+9.5%) |
| Sep 2016 | - | $56.81M(+10.0%) | $196.32M(+9.8%) |
| Jun 2016 | - | $51.63M(+16.8%) | $178.87M(+9.8%) |
| Mar 2016 | - | $44.19M(+1.2%) | $162.92M(+10.5%) |
| Dec 2015 | $147.47M(+59.1%) | $43.69M(+11.0%) | $147.47M(+9.2%) |
| Sep 2015 | - | $39.36M(+10.3%) | $135.01M(+14.1%) |
| Jun 2015 | - | $35.68M(+24.1%) | $118.34M(+5.3%) |
| Mar 2015 | - | $28.74M(-8.0%) | $112.33M(+21.2%) |
| Dec 2014 | $92.68M(+671.1%) | $31.23M(+37.7%) | $92.68M(+29.1%) |
| Sep 2014 | - | $22.69M(-23.5%) | $71.78M(+42.6%) |
| Jun 2014 | - | $29.68M(+226.8%) | $50.35M(+140.3%) |
| Mar 2014 | - | $9.08M(-12.1%) | $20.95M(+74.3%) |
| Dec 2013 | $12.02M(+712.1%) | $10.34M(+722.2%) | $12.02M(+333.3%) |
| Sep 2013 | - | $1.26M(+347.3%) | $2.77M(+72.5%) |
| Jun 2013 | - | $281.00K(+91.2%) | $1.61M(+13.4%) |
| Mar 2013 | - | $147.00K(-86.5%) | $1.42M(-4.1%) |
| Dec 2012 | $1.48M(+84.3%) | $1.09M(+1096.7%) | $1.48M(+242.4%) |
| Sep 2012 | - | $91.00K(0.0%) | $432.00K(+22.7%) |
| Jun 2012 | - | $91.00K(-56.3%) | $352.00K(-65.2%) |
| Mar 2012 | - | $208.00K(+395.2%) | $1.01M(+25.9%) |
| Dec 2011 | $803.00K(+657.5%) | $42.00K(+281.8%) | $803.00K(-110.2%) |
| Sep 2011 | - | $11.00K(-98.5%) | -$7.87M(-0.1%) |
| Jun 2011 | - | $750.00K(-108.7%) | -$7.88M(-8.7%) |
| Dec 2010 | $106.00K(-99.7%) | -$8.63M(+67.8%) | -$8.63M(+67.8%) |
| Dec 2009 | $37.92M(+326.7%) | -$5.14M | -$5.14M |
| Dec 2008 | $8.89M(+110.0%) | - | - |
| Dec 2007 | $4.23M | - | - |
FAQ
- What is Supernus Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual revenue year-on-year change?
- What is Supernus Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly revenue year-on-year change?
- What is Supernus Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM revenue year-on-year change?
What is Supernus Pharmaceuticals annual revenue?
The current annual revenue of SUPN is $661.82M
What is the all time high annual revenue for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual revenue is $667.24M
What is Supernus Pharmaceuticals annual revenue year-on-year change?
Over the past year, SUPN annual revenue has changed by +$54.30M (+8.94%)
What is Supernus Pharmaceuticals quarterly revenue?
The current quarterly revenue of SUPN is $149.82M
What is the all time high quarterly revenue for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly revenue is $177.35M
What is Supernus Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, SUPN quarterly revenue has changed by +$6.18M (+4.30%)
What is Supernus Pharmaceuticals TTM revenue?
The current TTM revenue of SUPN is $668.00M
What is the all time high TTM revenue for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM revenue is $668.50M
What is Supernus Pharmaceuticals TTM revenue year-on-year change?
Over the past year, SUPN TTM revenue has changed by +$70.60M (+11.82%)